Published in Physiol Behav on January 08, 2012
Chromatin remodeling--a novel strategy to control excessive alcohol drinking. Transl Psychiatry (2013) 1.11
Selection for drinking in the dark alters brain gene coexpression networks. Alcohol Clin Exp Res (2013) 1.04
Repeated cycles of binge-like ethanol (EtOH)-drinking in male C57BL/6J mice augments subsequent voluntary EtOH intake but not other dependence-like phenotypes. Alcohol Clin Exp Res (2013) 1.03
Positively correlated miRNA-mRNA regulatory networks in mouse frontal cortex during early stages of alcohol dependence. BMC Genomics (2013) 1.03
"Drinking in the dark" (DID) procedures: a model of binge-like ethanol drinking in non-dependent mice. Alcohol (2013) 1.02
Binge ethanol-drinking potentiates corticotropin releasing factor R1 receptor activity in the ventral tegmental area. Alcohol Clin Exp Res (2013) 0.96
Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation. Genes Brain Behav (2015) 0.92
Repeated binge-like ethanol drinking alters ethanol drinking patterns and depresses striatal GABAergic transmission. Neuropsychopharmacology (2013) 0.92
The small G protein H-Ras in the mesolimbic system is a molecular gateway to alcohol-seeking and excessive drinking behaviors. J Neurosci (2012) 0.90
Is the rodent maternal separation model a valid and effective model for studies on the early-life impact on ethanol consumption? Psychopharmacology (Berl) (2013) 0.90
High drinking in the dark mice: a genetic model of drinking to intoxication. Alcohol (2013) 0.88
Circadian rhythms and addiction: mechanistic insights and future directions. Behav Neurosci (2014) 0.87
Selective breeding for ethanol-related traits alters circadian phenotype. Alcohol (2013) 0.86
Alcohol disrupts sleep homeostasis. Alcohol (2014) 0.83
Ethanol and corticotropin releasing factor receptor modulation of central amygdala neurocircuitry: An update and future directions. Alcohol (2015) 0.81
Ghrelin-Derived Peptides: A Link between Appetite/Reward, GH Axis, and Psychiatric Disorders? Front Endocrinol (Lausanne) (2014) 0.81
Chronic Voluntary Ethanol Consumption Induces Favorable Ceramide Profiles in Selectively Bred Alcohol-Preferring (P) Rats. PLoS One (2015) 0.81
Nicotine administration in the cholinergic basal forebrain increases alcohol consumption in C57BL/6J mice. Alcohol Clin Exp Res (2014) 0.80
Rodent models of genetic contributions to motivation to abuse alcohol. Nebr Symp Motiv (2014) 0.80
Rapid tolerance development to the NREM sleep promoting effect of alcohol. Sleep (2014) 0.78
Chronic ethanol consumption profoundly alters regional brain ceramide and sphingomyelin content in rodents. ACS Chem Neurosci (2014) 0.78
Lateral hypothalamic melanocortin receptor signaling modulates binge-like ethanol drinking in C57BL/6J mice. Addict Biol (2015) 0.78
Effects of rearing conditions on behaviour and endogenous opioids in rats with alcohol access during adolescence. PLoS One (2013) 0.77
Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice. Behav Pharmacol (2014) 0.76
Modulation of Binge-like Ethanol Consumption by IL-10 Signaling in the Basolateral Amygdala. J Neuroimmune Pharmacol (2016) 0.75
Adenosinergic regulation of binge-like ethanol drinking and associated locomotor effects in male C57BL/6J mice. Pharmacol Biochem Behav (2015) 0.75
Acute binge alcohol administration reverses sleep-wake cycle in Sprague Dawley rats. Alcohol Clin Exp Res (2014) 0.75
Voluntary Binge-like Ethanol Consumption Site-specifically Increases c-Fos Immunoexpression in Male C57BL6/J Mice. Neuroscience (2017) 0.75
Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology (2001) 9.25
Binge drinking among US adults. JAMA (2003) 7.16
Age at drinking onset and alcohol dependence: age at onset, duration, and severity. Arch Pediatr Adolesc Med (2006) 7.10
Binge drinking and associated health risk behaviors among high school students. Pediatrics (2007) 5.18
Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol Behav (2005) 4.79
A role for brain stress systems in addiction. Neuron (2008) 4.71
Alcoholism: allostasis and beyond. Alcohol Clin Exp Res (2003) 4.05
Mouse inbred strain differences in ethanol drinking to intoxication. Genes Brain Behav (2007) 3.29
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction (2004) 3.27
Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci (2006) 3.13
Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats. Alcohol Clin Exp Res (2008) 2.98
The alcohol-preferring P rat and animal models of excessive alcohol drinking. Addict Biol (2006) 2.82
Alcohol-attributable deaths and years of potential life lost--United States, 2001. MMWR Morb Mortal Wkly Rep (2004) 2.81
Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry (2006) 2.70
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci U S A (2007) 2.68
Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther (2006) 2.44
Alcoholism and smoking. J Stud Alcohol (1990) 2.02
Alcohol consumption and smoking status: the role of smoking cessation. Biomed Pharmacother (2004) 1.77
Protein expression changes in the nucleus accumbens and amygdala of inbred alcohol-preferring rats given either continuous or scheduled access to ethanol. Alcohol (2006) 1.75
A line of mice selected for high blood ethanol concentrations shows drinking in the dark to intoxication. Biol Psychiatry (2008) 1.75
Binge drinking in the preconception period and the risk of unintended pregnancy: implications for women and their children. Pediatrics (2003) 1.74
GABAergic modulation of binge-like ethanol intake in C57BL/6J mice. Pharmacol Biochem Behav (2007) 1.63
Binge drinking and health-related quality of life: do popular perceptions match reality? Am J Prev Med (2004) 1.61
Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol. Alcohol Clin Exp Res (2011) 1.57
Age of alcohol-dependence onset: associations with severity of dependence and seeking treatment. Pediatrics (2006) 1.55
Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice. Psychopharmacology (Berl) (2007) 1.51
Accumbens neurochemical adaptations produced by binge-like alcohol consumption. Psychopharmacology (Berl) (2007) 1.50
Binge drinking upregulates accumbens mGluR5-Homer2-PI3K signaling: functional implications for alcoholism. J Neurosci (2009) 1.47
CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology (2010) 1.44
Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res (2007) 1.43
A procedure to produce high alcohol intake in mice. Psychopharmacology (Berl) (2004) 1.38
Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine. Eur J Pharmacol (1998) 1.37
Adolescent binge drinking alters adult brain neurotransmitter gene expression, behavior, brain regional volumes, and neurochemistry in mice. Alcohol Clin Exp Res (2011) 1.33
Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res (2000) 1.31
Molecular profiles of drinking alcohol to intoxication in C57BL/6J mice. Alcohol Clin Exp Res (2011) 1.27
Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice. Psychopharmacology (Berl) (2009) 1.26
Alcohol preference drinking in a mouse line selectively bred for high drinking in the dark. Alcohol (2010) 1.25
State alcohol-use estimates among youth and adults, 1993-2005. Am J Prev Med (2009) 1.23
Agonism of the endocannabinoid system modulates binge-like alcohol intake in male C57BL/6J mice: involvement of the posterior ventral tegmental area. Neuroscience (2009) 1.22
Site-specific microinjection of baclofen into the anterior ventral tegmental area reduces binge-like ethanol intake in male C57BL/6J mice. Behav Neurosci (2009) 1.20
Criteria for an animal model of alcoholism. Pharmacol Biochem Behav (1974) 1.20
Acute effects of acamprosate and MPEP on ethanol Drinking-in-the-Dark in male C57BL/6J mice. Alcohol Clin Exp Res (2008) 1.18
Gene expression changes in the nucleus accumbens of alcohol-preferring rats following chronic ethanol consumption. Pharmacol Biochem Behav (2009) 1.17
Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci (2005) 1.16
Effects of food availability and administration of orexigenic and anorectic agents on elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res (2008) 1.14
Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption. Neuroscience (2007) 1.12
Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons. Alcohol Clin Exp Res (2010) 1.08
Effect of ethanol on the regulation of corticotropin-releasing factor (CRF) gene expression. Mol Cell Neurosci (2005) 1.07
Role of mu and delta opioid receptors in alcohol drinking behaviour. Curr Drug Abuse Rev (2008) 1.06
Modeling binge-like ethanol drinking by peri-adolescent and adult P rats. Pharmacol Biochem Behav (2011) 1.06
Recent animal models of alcoholism. Alcohol Res Health (2000) 1.06
Changes in gene expression in regions of the extended amygdala of alcohol-preferring rats after binge-like alcohol drinking. Alcohol (2010) 1.02
Circadian feeding and drinking patterns of genetically obese mice fed solid chow diet. Physiol Behav (1988) 1.00
Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors. Neuropsychopharmacology (2012) 0.99
Deletion of agouti-related protein blunts ethanol self-administration and binge-like drinking in mice. Genes Brain Behav (2009) 0.99
The Majchrowicz binge alcohol protocol: an intubation technique to study alcohol dependence in rats. Curr Protoc Neurosci (2008) 0.99
Association of lifetime alcohol drinking trajectories with cardiometabolic risk. J Clin Endocrinol Metab (2007) 0.99
Effects of melanocortin receptor ligands on ethanol intake and opioid peptide levels in alcohol-preferring AA rats. Brain Res Bull (2002) 0.98
Using drinking in the dark to model prenatal binge-like exposure to ethanol in C57BL/6J mice. Dev Psychobiol (2008) 0.97
Purinergic type 2 receptors at GABAergic synapses on ventral tegmental area dopamine neurons are targets for ethanol action. J Pharmacol Exp Ther (2008) 0.95
GABAA receptors in the posterior, but not anterior, ventral tegmental area mediate Ro15-4513-induced attenuation of binge-like ethanol consumption in C57BL/6J female mice. Behav Brain Res (2011) 0.94
Decreased immunoreactivity of the melanocortin neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) after chronic ethanol exposure in Sprague-Dawley rats. Alcohol Clin Exp Res (2007) 0.93
Lobeline and cytisine reduce voluntary ethanol drinking behavior in male C57BL/6J mice. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.93
Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking. Alcohol (2010) 0.92
Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice. Alcohol Clin Exp Res (2011) 0.91
Ethanol is a fast channel inhibitor of P2X4 receptors. J Pharmacol Exp Ther (2011) 0.90
Pharmacologically targeting the P2rx4 gene on maintenance and reinstatement of alcohol self-administration in rats. Pharmacol Biochem Behav (2011) 0.90
Increased consumption of ethanol and sugar water in mice lacking the dopamine D2 long receptor. Alcohol (2011) 0.90
Ghrelin in eating disorders. Mol Cell Endocrinol (2011) 0.83
Involvement of the endocannabinoid system in alcohol dependence: the biochemical, behavioral and genetic evidence. Drug Alcohol Depend (2011) 0.83
Central neuropeptide Y alters ethanol-induced sedation, but not ethanol intake, in C57BL/6 mice. Alcohol (2003) 0.80
CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology (2010) 1.44
Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res (2007) 1.43
Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice. J Neurosci (2012) 1.30
Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS Neurol Disord Drug Targets (2010) 1.19
Effects of food availability and administration of orexigenic and anorectic agents on elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res (2008) 1.14
Effects of melanocortin receptor activation and blockade on ethanol intake: a possible role for the melanocortin-4 receptor. Alcohol Clin Exp Res (2005) 1.06
The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. Alcohol Clin Exp Res (2007) 1.05
Repeated cycles of binge-like ethanol (EtOH)-drinking in male C57BL/6J mice augments subsequent voluntary EtOH intake but not other dependence-like phenotypes. Alcohol Clin Exp Res (2013) 1.03
MTII-induced reduction of voluntary ethanol drinking is blocked by pretreatment with AgRP-(83-132). Neuropeptides (2003) 1.03
The alcohol deprivation effect in C57BL/6J mice is observed using operant self-administration procedures and is modulated by CRF-1 receptor signaling. Alcohol Clin Exp Res (2008) 1.01
Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors. Neuropsychopharmacology (2012) 0.99
Predictors of high ethanol consumption in RIIbeta knock-out mice: assessment of anxiety and ethanol-induced sedation. Alcohol Clin Exp Res (2004) 0.98
Neuropeptide y and alcoholism: genetic, molecular, and pharmacological evidence. Alcohol Clin Exp Res (2003) 0.98
Neuropeptide Y conjugated to saporin alters anxiety-like behavior when injected into the central nucleus of the amygdala or basomedial hypothalamus in BALB/cJ mice. Peptides (2010) 0.97
Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior. Alcohol (2012) 0.94
Decreased immunoreactivity of the melanocortin neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) after chronic ethanol exposure in Sprague-Dawley rats. Alcohol Clin Exp Res (2007) 0.93
Inhibition of protein kinase A activity interferes with long-term, but not short-term, memory of conditioned taste aversions. Behav Neurosci (2002) 0.92
Comparison of basal neuropeptide Y and corticotropin releasing factor levels between the high ethanol drinking C57BL/6J and low ethanol drinking DBA/2J inbred mouse strains. Alcohol Clin Exp Res (2005) 0.92
Assessment of voluntary ethanol consumption and the effects of a melanocortin (MC) receptor agonist on ethanol intake in mutant C57BL/6J mice lacking the MC-4 receptor. Alcohol Clin Exp Res (2011) 0.87
Increased consumption but not operant self-administration of ethanol in mice lacking the RIIbeta subunit of protein kinase A. Alcohol Clin Exp Res (2006) 0.86
Elevated anxiety-like behavior following ethanol exposure in mutant mice lacking neuropeptide Y (NPY). Drug Alcohol Depend (2007) 0.86
Control of food intake by MC4-R signaling in the lateral hypothalamus, nucleus accumbens shell and ventral tegmental area: interactions with ethanol. Behav Brain Res (2012) 0.84
Ethanol-induced increase of agouti-related protein (AgRP) immunoreactivity in the arcuate nucleus of the hypothalamus of C57BL/6J, but not 129/SvJ, inbred mice. Alcohol Clin Exp Res (2010) 0.84
Conditioned taste aversion memory and c-Fos induction are disrupted in RIIbeta-protein kinase A mutant mice. Behav Brain Res (2003) 0.83
MC4-R signaling within the nucleus accumbens shell, but not the lateral hypothalamus, modulates ethanol palatability in rats. Behav Brain Res (2012) 0.82
Altered GABAA receptor expression and seizure threshold following acute ethanol challenge in mice lacking the RIIβ subunit of PKA. Neurochem Res (2013) 0.81
Peripheral and central administration of a selective neuropeptide Y Y1 receptor antagonist suppresses ethanol intake by C57BL/6J mice. Alcohol Clin Exp Res (2004) 0.81
Adolescent binge-like ethanol exposure reduces basal α-MSH expression in the hypothalamus and the amygdala of adult rats. Pharmacol Biochem Behav (2013) 0.81
Induction of a brainstem correlate of conditioned taste aversion expression: role of the pontine parabrachial nucleus. Behav Brain Res (2002) 0.80
Binge-like consumption of ethanol and other salient reinforcers is blocked by orexin-1 receptor inhibition and leads to a reduction of hypothalamic orexin immunoreactivity. Alcohol Clin Exp Res (2015) 0.80
Decreased immunoreactivity of the polypeptide precursor pro-opiomelanocortin (POMC) and the prohormone convertase pc1/3 after chronic ethanol exposure in Sprague-Dawley rats. Alcohol Clin Exp Res (2012) 0.80
Nitrous oxide-induced c-Fos expression in the rat brain. Brain Res (2003) 0.78
Neuropeptide Y signaling modulates the expression of ethanol-induced behavioral sensitization in mice. Addict Biol (2011) 0.77
Histone acetylation in the nucleus accumbens shell modulates ethanol-induced locomotor activity in DBA/2J mice. Alcohol Clin Exp Res (2014) 0.76
Reduced anorexigenic efficacy of leptin, but not of the melanocortin receptor agonist melanotan-II, predicts diet-induced obesity in rats. Endocrinology (2005) 0.76